SLNP-based CDK4- targeted nanotherapy against glioblastoma.
Saved in:
| Title: | SLNP-based CDK4- targeted nanotherapy against glioblastoma. |
|---|---|
| Authors: | Ghani U; Molecular Immunology Laboratory, Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan., Ghori FK; Molecular Immunology Laboratory, Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan., Qamar MU; Institute of Microbiology, Faculty of Life Sciences, Government College University Faisalabad, Faisalabad, Pakistan.; Division of Infectious Disease and Department of Medicine, University of Geneva, Geneva, Switzerland., Khan H; Molecular Immunology Laboratory, Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan., Azad B; Materials And Modeling Lab, School of Interdisciplinary Engineering and Sciences, National University of Sciences and Technology, Islamabad, Pakistan., Habib S; Molecular Immunology Laboratory, Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan., Justin S; Molecular Immunology Laboratory, Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan., Khan IN; Cancer Cell Culture and Precision Oncomedicine Lab, Institute of Basic Medical Sciences (IBMS), Khyber Medical University, Peshawar, Pakistan.; Department of Pharmaceutical Sciences, Taxes A&M Health Science Center, Joe H. Reynolds Medical Sciences Build, College Station, TX, United States., Shah TA; College of Agriculture Engineering and Food Sciences, Shandong University of Technology, Zibo, China., Shazly GA; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Bourhia M; Department of Chemistry and Biochemistry, Faculty of Medicine and Pharmacy, Ibn Zohr University, Laayoune, Morocco., Perveen F; Materials And Modeling Lab, School of Interdisciplinary Engineering and Sciences, National University of Sciences and Technology, Islamabad, Pakistan., Javed A; Molecular Immunology Laboratory, Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Nov 22; Vol. 14, pp. 1455816. Date of Electronic Publication: 2024 Nov 22 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2024.1455816 |
